Reaction
Hypertensive Encephalopathy reporting signals
As of the last recalculation, Hypertensive Encephalopathy appears in 591 FAERS reports alongside 15 co-occurring drug terms. The strongest observed disproportionality signal is LABETALOL (PRR 46.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Labetalol | 17 | 46.2 | 46.3 |
| Bupivacaine | 12 | 46.1 | 46.2 |
| Indomethacin | 14 | 38.1 | 38.1 |
| Epoetin Alfa | 10 | 30.2 | 30.2 |
| Methoxy Polyethylene Glycol-Epoetin Beta | 9 | 29.1 | 29.2 |
| Guanfacine | 5 | 22.6 | 22.6 |
| Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride And Dextrose | 3 | 13.0 | 13.0 |
| Carfilzomib | 9 | 11.4 | 11.4 |
| Lenvatinib | 10 | 10.9 | 10.9 |
| Abiraterone | 4 | 10.4 | 10.4 |
| Axitinib | 5 | 9.1 | 9.1 |
| Minoxidil Foam 5% (Womens) | 6 | 6.5 | 6.5 |
| Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride | 5 | 5.7 | 5.7 |
| Droxidopa | 3 | 4.9 | 4.9 |
| Minoxidil | 6 | 4.7 | 4.7 |